Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer
Clinical trial NCT00318643 · COMPLETED
Trial details
- NCT number
- NCT00318643
- Sponsor
- Halozyme Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-30
- Primary completion
- 2009-08-11
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.